The new industrial design law entered into force in Kosovo on
January 15, 2016. The law has been harmonized with the Directive
98/71/EC of the European Parliament and of the Council of 13
October 1998 on the legal protection of designs and the Directive
2004/48/EC of the European Parliament and of the Council of 29
April 2004 on the enforcement of intellectual property rights.
Under the new law, the renewal request should be submitted
within the 12-month period prior to the expiration of design right.
The former law did not specify the exact time frame.
The new law clarifies the procedure for the assignment of rights
by including necessary steps to be taken and the required
documents. Full or partial transfer of rights is possible; an
assignment contract or a certified statement is necessary in order
to register such rights.
As the previous law, the new law also excludes the possibility
for a legal person to be considered as the designer; the designer
can only be a natural person.
As under the former law, formal examination is the only
examination performed by the IPO.
The new law introduces compensation for damages as a legal
remedy, under the general rules relating to unjust enrichment.
Under the new law, industrial designs are also protected under
copyright law. The former law did not include any provisions on the
relationship of designs and other IP rights.
The applicable bylaw remains the Administrative Instruction
No.11/2012 on the industrial design registration procedure.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
To print this article, all you need is to be registered on Mondaq.com.
Click to Login as an existing user or Register so you can print this article.
1.The trade mark shall not entitle the proprietor to prohibit its use in relation to goods which have been put on the market in the Community under that trade mark by the proprietor or with his consent.
The UK government has not yet invoked Article 50 of the Treaty on European Union (this is likely to happen by the end of March), and the UK's actual exit from the European Union is at least two years away.
Without doubt Malta offers significant opportunities for the generics drugs Industry and the
evidence for this lies in the pharmaceutical patenting history of the country and in its legislative
In a landmark judgment, the High Court has granted a novel type of declaratory relief to clear the route to market for a product facing a raft of pending patent applications...
Some comments from our readers… “The articles are extremely timely and highly applicable” “I often find critical information not available elsewhere” “As in-house counsel, Mondaq’s service is of great value”
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).